|
Volumn 17, Issue 10, 2003, Pages 1298-1300
|
A selective inhibitor of inducible nitric oxide synthase inhibits exhaled breath nitric oxide in healthy volunteers and asthmatics.
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
DRUG DERIVATIVE;
ENZYME INHIBITOR;
HOMOARGININE;
INDUCIBLE NITRIC OXIDE SYNTHASE;
L N(6) (1 IMINOETHYL)LYSINE TETRAZOLE AMIDE;
L-N(6)-(1-IMINOETHYL)LYSINE TETRAZOLE-AMIDE;
LYSINE;
N(6) (1 IMINOETHYL)LYSINE;
N(6)-(1-IMINOETHYL)LYSINE;
NITRIC OXIDE;
NITRIC OXIDE SYNTHASE;
NOS2A PROTEIN, HUMAN;
PRODRUG;
ADULT;
ARTICLE;
ASTHMA;
BREATH ANALYSIS;
CELL CULTURE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DOUBLE BLIND PROCEDURE;
DRUG ANTAGONISM;
DRUG EFFECT;
ENZYMOLOGY;
FEMALE;
HUMAN;
MALE;
ORAL DRUG ADMINISTRATION;
RANDOMIZED CONTROLLED TRIAL;
RESPIRATORY TRACT MUCOSA;
ADMINISTRATION, ORAL;
ADULT;
ASTHMA;
BREATH TESTS;
CELLS, CULTURED;
CROSS-OVER STUDIES;
DOUBLE-BLIND METHOD;
ENZYME INHIBITORS;
FEMALE;
HOMOARGININE;
HUMANS;
LYSINE;
MALE;
NITRIC OXIDE;
NITRIC OXIDE SYNTHASE;
NITRIC OXIDE SYNTHASE TYPE II;
PRODRUGS;
RESPIRATORY MUCOSA;
MLCS;
MLOWN;
|
EID: 0038604348
PISSN: None
EISSN: 15306860
Source Type: Journal
DOI: 10.1096/fj.02-0633fje Document Type: Article |
Times cited : (186)
|
References (0)
|